MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
Vs. 08
20-10-2009
Reference probes + control fragments Synthetic 'home-made' probes
Vs. 15
18-03-2016
Reference probes + control fragments Synthetic 'home-made' probes
Vs. 06
05-11-2010
CHD7 8q12.2 Charge syndrome
Vs. 08
22-11-2011
CHD7 8q12.2 Charge syndrome
Vs. 10
21-12-2012
CHD7 8q12.2 Charge syndrome
Vs. 11
15-07-2015
CHD7 8q12.2 Charge syndrome
Vs. 12
31-08-2016
CHD7 8q12.2 Charge syndrome
Vs. 05
19-08-2011
IKZF1 7p12.2 Acute lymphoplastic leukemia (ALL), CML
Vs. 07
13-07-2015
IKZF1 7p12.2 Acute lymphoplastic leukemia (ALL), CML
Vs. 08
17-08-2015
IKZF1 7p12.2 Acute lymphoplastic leukemia (ALL), CML
Vs. 04
05-06-2009
PKLR 1q22 Haemolytic Anaemia, hereditary non-spherocytic
Vs. 06
01-09-2011
PKLR 1q22 Haemolytic Anaemia, hereditary non-spherocytic
Vs. 09
01-03-2013
PKLR 1q22 Haemolytic Anaemia, hereditary non-spherocytic
Vs. 10
15-07-2015
PKLR 1q22 Haemolytic Anaemia, hereditary non-spherocytic
Vs. 11
24-02-2016
PKLR 1q22 Haemolytic Anaemia, hereditary non-spherocytic
Vs. 03
11-01-2007
SH2D1A Xq25 Lymphoproliferative syndrome, x-linked (XLP). Duncan disease
Vs. 10
18-03-2013
SH2D1A Xq25 Lymphoproliferative syndrome, x-linked (XLP). Duncan disease
P205-B1 Vs. 12 06-04-2016 SH2D1A Xq25 Lymphoproliferative syndrome, x-linked (XLP). Duncan disease
Vs. 05
11-09-2009
F9 Xq27.1 Factor IX deficiency, Christmas disease
Vs. 07
02-09-2011
F9 Xq27.1 Factor IX deficiency, Christmas disease
P207-C2 Vs. 08 12-06-2012 F9 Xq27.1 Factor IX deficiency, Christmas disease
P207-C2 Vs. 09 16-12-2012 F9 Xq27.1 Factor IX deficiency, Christmas disease
P207-C3 Vs. 10 11-03-2015 F9 Xq27.1 Factor IX deficiency, Christmas disease
P207-C3 Vs. 11 05-02-2016 F9 Xq27.1 Factor IX deficiency, Christmas disease
Vs. 04
12-12-2006
2p, 3p, 6p, 8p Subtelomere screening
Vs. 12
29-06-2011
2p, 3p, 6p, 8p Subtelomere screening
Vs. 13
09-09-2011
2p, 3p, 6p, 8p Subtelomere screening
Vs. 15
22-06-2015
2p, 3p, 6p, 8p Subtelomere screening
Vs. 16
07-09-2017
2p, 3p, 6p, 8p Subtelomere screening
Vs. 05
22-12-2009
GLDC 9p22 Glycine encephalopathy
Vs. 07
21-12-2012
GLDC 9p22 Glycine encephalopathy
Vs. 08
21-08-2014
GLDC 9p22 Glycine encephalopathy
Vs. 05
29-09-2010
BTK Xq21.3-q22 Agammaglobulinemia
P210-A3 Vs. 08 10-09-2011 BTK Xq21.3-q22 Agammaglobulinemia
Vs. 09
17-11-2010
SPAST 2p22, NIPA1 15q11 Hereditary Spastic Paraplegias (HSPs) region
Vs. 13
01-03-2013
SPAST 2p22, NIPA1 15q11 Hereditary Spastic Paraplegias (HSPs) region
Vs. 15
29-09-2014
SPAST 2p22, NIPA1 15q11 Hereditary Spastic Paraplegias (HSPs) region
Vs. 16
27-10-2016
SPAST 2p22, NIPA1 15q11 Hereditary Spastic Paraplegias (HSPs) region
Vs. 11 05-07-2013 RPL11, RPL35A, RPS17, RPS19, RPS26, RPL5 Diamond-Blackfan anemia (DBA)
P212-C1 Vs.12 13-03-2015 RPL11, RPL35A, RPS17, RPS19, RPS26, RPL5 Diamond-Blackfan anemia (DBA)
P212-C2 Vs.14 07-09-2017 RPL11, RPL35A, RPS17, RPS19, RPS26, RPL5 Diamond-Blackfan anemia (DBA)
Vs. 14 22-04-2014 REEP1 (SPG31) 2p11.2, SPG7 16q24.3 Hereditary spastic paraplegias (HSPs)
Vs. 15 23-02-2016 REEP1 (SPG31) 2p11.2, SPG7 16q24.3 Hereditary spastic paraplegias (HSPs)
P213-B2 Vs. 16 24-06-2016 REEP1 (SPG31) 2p11.2, SPG7 16q24.3 Hereditary spastic paraplegias (HSPs)
Vs. 07
21-12-2012
COL2A1 12q13.11-q13.2 Skeletal disorders, Achondrogenesis, Chondrodysplasia, Early onset familial Osteoarthritis, SED congenital, Langer-Saldino achondrogenesis, Kniest dysplasia, Stickler syndrome, Spondyloepimetaphyseal
Vs. 08 04-10-2013 COL2A1 12q13.11-q13.2 Skeletal disorders, Achondrogenesis, Chondrodysplasia, Early onset familial Osteoarthritis, SED congenital, Langer-Saldino achondrogenesis, Kniest dysplasia, Stickler syndrome, Spondyloepimetaphyseal
P214-B2 Vs. 09 12-03-2015 COL2A1 12q13.11-q13.2 Skeletal disorders, Achondrogenesis, Chondrodysplasia, Early onset familial Osteoarthritis, SED congenital, Langer-Saldino achondrogenesis, Kniest dysplasia, Stickler syndrome, Spondyloepimetaphyseal
P214-C1 Vs. 10 28-07-2016 COL2A1 12q13.11-q13.2 Skeletal disorders, Achondrogenesis, Chondrodysplasia, Early onset familial Osteoarthritis, SED congenital, Langer-Saldino achondrogenesis, Kniest dysplasia, Stickler syndrome, Spondyloepimetaphyseal
Vs. 07
26-10-2010
EXT1 8q24, EXT2 11p12 Multiple Osteochondromas
B215-B1 Vs. 08 18-09-2011 EXT1 8q24, EXT2 11p12 Multiple Osteochondromas
B215-B1 Vs. 09 21-12-2012 EXT1 8q24, EXT2 11p12 Multiple Osteochondromas
B215-B2 Vs. 10 28-10-2013 EXT1 8q24, EXT2 11p12 Multiple Osteochondromas
B215-B2 Vs. 11 29-10-2014 EXT1 8q24, EXT2 11p12 Multiple Osteochondromas
B215-B3 Vs. 12 18-05-2016 EXT1 8q24, EXT2 11p12 Multiple Osteochondromas
P216-B1 Vs. 11 19-09-2013 GH1, LHX4, POU1F1, HESX1, PROP1, GHRHR, LHX3 Growth Hormone Deficiency (GHD)
P216-B1 Vs. 12 26-02-2015 GH1, LHX4, POU1F1, HESX1, PROP1, GHRHR, LHX3 Growth Hormone Deficiency (GHD)
P216-B1 Vs. 13 01-08-2015 GH1, LHX4, POU1F1, HESX1, PROP1, GHRHR, LHX3 Growth Hormone Deficiency (GHD)
Vs. 07
18-09-2011
IGFR1, IGFBP3 Insulin-like growth factor 1 receptor (IGF1R)
Vs. 09
31-01-2014
IGFR1, IGFBP3 Insulin-like growth factor 1 receptor (IGF1R)
Vs. 10
27-07-2017
IGFR1, IGFBP3 Insulin-like growth factor 1 receptor (IGF1R)
Vs. 05
18-09-2011
LPL 8p21.3 LPL deficiency
P218-B1 Vs. 06 21-12-2012 LPL 8p21.3 LPL deficiency
Vs. 07
25-03-2013
LPL 8p21.3 LPL deficiency
Vs. 08
15-07-2015
LPL 8p21.3 LPL deficiency
Vs. 09
27-10-2015
LPL 8p21.3 LPL deficiency
Vs. 06
04-11-2010
PAX6 11p13, SOX2 3q26, WT1, 11p13 Ocular malformations, hereditary
Vs. 08
07-02-2012
PAX6 11p13, SOX2 3q26, WT1, 11p13 Ocular malformations, hereditary
Vs. 09 21-12-2012 PAX6 11p13, SOX2 3q26, WT1, 11p13 Ocular malformations, hereditary
Vs. 10 17-06-2015 PAX6 11p13, SOX2 3q26, WT1, 11p13 Ocular malformations, hereditary
Vs. 11 11-12-2015 PAX6 11p13, SOX2 3q26, WT1, 11p13 Ocular malformations, hereditary
Vs. 12 13-01-2017 PAX6 11p13, SOX2 3q26, WT1, 11p13 Ocular malformations, hereditary